The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist. To address this critical ...

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it ...

Dr Temitope Ilori, the Director-General of the National Agency for the Control of AIDS (NACA), says plans are on to begin ...

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

Gilead Sciences, Inc. (NASDAQ:GILD), a leading biopharmaceutical company with a market capitalization of $119.32 billion, has been making significant strides in its core HIV franchise while expanding ...

The future of PEPFAR, the U.S. government's global effort to combat HIV/AIDS, has been called into question amid a broader ...

Researchers at the University of Massachusetts Amherst have quantified the impacts of a constellation of social factors on ...

Macrophages, like CD4 + T cells, serve as the primary target cells for HIV and facilitate in the virus’s dissemination throughout the body. HIV infection significantly alters the body’s immune ...

A team of scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of Regensburg has unveiled insights into how HIV-1, the virus responsible ...

She is among a number of people with HIV who are taking part in a HSE campaign to address misconceptions around the virus and help reduce the stigma associated with it. The couple married five ...